Literature DB >> 24867289

Role of Rho kinases in abnormal and normal hematopoiesis.

Raghuveer Singh Mali1, Simryn Kapur, Reuben Kapur.   

Abstract

PURPOSE OF REVIEW: Rho kinases (ROCKs) are involved in regulating a variety of physiologic functions including cytoskeletal reorganization, migration, adhesion, survival and proliferation. They do so via activating several different downstream substrates such as myosin light chain phosphatase, LIM kinase and ezrin/radixin/moesin proteins. To date, most of the conclusions with regard to the function of ROCKs have involved the use of cell line models, pharmacologic inhibitors and dominant negative approaches. Importantly, the role of ROCK in hematopoiesis or leukemogenesis in the context of whole organism remains poorly understood. RECENT
FINDINGS: Recent studies utilizing mice deficient in the expression of ROCK1 have begun to shed some light into the physiologic role(s) of ROCK in both normal and abnormal hematopoiesis. Findings, thus far, suggest that ROCK plays an essential role in regulating growth and survival in different hematopoietic lineages via distinct mechanisms, in part, by utilizing distinct downstream substrates including maintaining the activation of tumor-suppressor genes.
SUMMARY: In blood cells, emerging data suggest that ROCK plays an essential role in negatively regulating inflammatory and erythropoietic stress and positively regulates the growth and survival of leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867289      PMCID: PMC4372239          DOI: 10.1097/MOH.0000000000000056

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  28 in total

1.  Rac and Rho.

Authors:  A Ridley
Journal:  Curr Biol       Date:  1999-03-11       Impact factor: 10.834

2.  Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.

Authors:  S Arber; F A Barbayannis; H Hanser; C Schneider; C A Stanyon; O Bernard; P Caroni
Journal:  Nature       Date:  1998-06-25       Impact factor: 49.962

Review 3.  The GTP-binding protein Rho.

Authors:  A J Ridley
Journal:  Int J Biochem Cell Biol       Date:  1997-11       Impact factor: 5.085

4.  Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation.

Authors:  Y Kureishi; S Kobayashi; M Amano; K Kimura; H Kanaide; T Nakano; K Kaibuchi; M Ito
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

5.  p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions.

Authors:  T Ishizaki; M Naito; K Fujisawa; M Maekawa; N Watanabe; Y Saito; S Narumiya
Journal:  FEBS Lett       Date:  1997-03-10       Impact factor: 4.124

6.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

7.  Regulation of PTEN by Rho small GTPases.

Authors:  Zhong Li; Xuemei Dong; Xiemei Dong; Zhenglong Wang; Wenzhong Liu; Ning Deng; Yu Ding; Liuya Tang; Tim Hla; Rong Zeng; Lin Li; Dianqing Wu
Journal:  Nat Cell Biol       Date:  2005-03-27       Impact factor: 28.824

8.  Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

Authors:  M Maekawa; T Ishizaki; S Boku; N Watanabe; A Fujita; A Iwamatsu; T Obinata; K Ohashi; K Mizuno; S Narumiya
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

9.  Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase).

Authors:  M Amano; M Ito; K Kimura; Y Fukata; K Chihara; T Nakano; Y Matsuura; K Kaibuchi
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

10.  An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.

Authors:  Benjamin L Ebert; Michele M Lee; Jennifer L Pretz; Aravind Subramanian; Raymond Mak; Todd R Golub; Colin A Sieff
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

View more
  6 in total

1.  Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.

Authors:  Shaobo Huang; Xu Li; Weiqi Gu; Xiaoyi Li; Jingjing Zhao; Jueheng Wu; Junchao Cai; Xianming Feng; Tianyu Tao
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 2.  The double face of Morgana in tumorigenesis.

Authors:  Mara Brancaccio; Stefania Rocca; Laura Seclì; Elena Busso; Federica Fusella
Journal:  Oncotarget       Date:  2015-12-15

Review 3.  Novel Insights into the Roles of Rho Kinase in Cancer.

Authors:  Lei Wei; Michelle Surma; Stephanie Shi; Nathan Lambert-Cheatham; Jianjian Shi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-01-02       Impact factor: 4.291

Review 4.  Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.

Authors:  Maria Teresa Bochicchio; Valeria Di Battista; Pietro Poggio; Giovanna Carrà; Alessandro Morotti; Mara Brancaccio; Alessandro Lucchesi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 5.  Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.

Authors:  Stefania Rocca; Giovanna Carrà; Pietro Poggio; Alessandro Morotti; Mara Brancaccio
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

Review 6.  Rho Kinases in Embryonic Development and Stem Cell Research.

Authors:  Jianjian Shi; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-01-19       Impact factor: 4.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.